Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM16M6Other or unspecified drugs, medicaments and biological substances
Contrast media
XM2S71X-ray contrast media, iodinated
XM4AG5Watersoluble, nephrotropic, low osmolar X-ray contrast media

XM5LW4 category

Iotroxic acid

Also indexed as

Iotroxic acidIoversolMeglumine iotroxate

Nearby in Watersoluble, nephrotropic, low osmolar X-ray contrast media

XM3WB6Metrizamide
XM3R65Iohexol
XM5EP5Ioxaglic acid
XM8C50Iopamidol
XM4UK7Iopromide
XM8VT7Iotrolan
XM6227Iopentol
XM8NA7Iodixanol

PreviousXM8VT7 — Iotrolan NextXM6227 — Iopentol

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
XM4G94Antidepressants
XM98Y0Cannabinoids or hallucinogens
XM9NV2Opioids
XM0RE9Psychostimulants
XM3L75Sedative hypnotic drugs or other central nervous system depressants
XM16M6Other or unspecified drugs, medicaments and biological substances
XM0YW5Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological or dental drugs
14 more
Iron chelating agents
Drugs for treatment of hyperkalaemia, hypercalcaemia and hyperphosphataemia
Detoxifying agents for antineoplastic treatment
Protectives against UV-radiation for systemic use
Antipsoriatics for systemic use
Vitamin A derivative and other anti-acne preparations for systemic use
Agents used in diagnostic tests, not elsewhere classified
Medical gases
Contrast media
1 more
XM2S71X-ray contrast media, iodinated
X-ray contrast media, non-iodinated
XM05Z9Magnetic resonance imaging contrast media
XM5TN4Ultrasound contrast media
XM9320Diagnostic radiopharmaceuticals
XM45C8Therapeutic radiopharmaceuticals
XM7YS2Watersoluble, nephrotropic, high osmolar X-ray contrast media
XM4AG5Watersoluble, nephrotropic, low osmolar X-ray contrast media
XM0KA6Watersoluble, hepatotropic X-ray contrast media
XM0LK3Non-watersoluble X-ray contrast media
XM6XU2Diatrizoate
XM8QZ2Iodophthalein sodium
XM3WB6Metrizamide
XM3R65Iohexol
XM5EP5Ioxaglic acid
XM8C50Iopamidol
XM4UK7Iopromide
XM8VT7Iotrolan
XM5LW4Iotroxic acid
XM6227Iopentol
XM8NA7Iodixanol
XM75B4Iomeprol
XM79B6Iobitridol
XM6VV1Ioxilan

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact